Article
Antigenicity and immunogenicity of the N-terminal 33-kDa processing fragment of the Plasmodium falciparum merozoite surface protein 1, MSP1: implications for vaccine development.
Vaccine - 5 Jan 2007
Yuen Don, Leung Wai-Hang, Cheung Randy, Hashimoto Caryn, Ng Sui Fung, Ho Walter, Hui George
Abstract excerpt
The Plasmodium falciparum merozoite surface protein 1 (MSP1), MSP1-42 and MSP1-19 are protective malaria vaccines. MSP1-42 is cleaved to form MSP1-33 and MSP1-19. The role of MSP1-33 in immunity is unclear. We investigated the antibody responses to MSP1-33; and to MSP1-33Trunc, in which major conserved sequences were excised. While anti-MSP1-33 antibodies were subdominant in the anti-MSP1-42 responses,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
